Comparative effectiveness and implementation research: Directions for Neurology
暂无分享,去创建一个
[1] A Eugene Washington,et al. The Patient-Centered Outcomes Research Institute--promoting better information, decisions, and health. , 2011, The New England journal of medicine.
[2] M. C. Gibbons,et al. Preventing Recurrence of Thromboembolic Events through Coordinated Treatment in the District of Columbia , 2011, International journal of stroke : official journal of the International Stroke Society.
[3] J. Tseng,et al. Underutilization of therapy for hepatocellular carcinoma in the medicare population , 2011, Cancer.
[4] William E. Cunningham,et al. Randomized, Controlled Trial of an Intervention to Enable Stroke Survivors Throughout the Los Angeles County Safety Net to “Stay With the Guidelines” , 2011, Circulation. Cardiovascular quality and outcomes.
[5] C. McCulloch,et al. NIH Disease Funding Levels and Burden of Disease , 2011, PloS one.
[6] R. Finkel,et al. Widening gap in age at muscular dystrophy–associated death between blacks and whites, 1986–2005 , 2010, Neurology.
[7] N. Dreyer,et al. Registries for Evaluating Patient Outcomes: A User’s Guide , 2010 .
[8] Heather M. Tavel,et al. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors Versus &bgr;-Blockers as Second-Line Therapy for Hypertension , 2010, Circulation. Cardiovascular quality and outcomes.
[9] Elizabeth W Paxton,et al. Kaiser Permanente National Total Joint Replacement Registry: Aligning Operations With Information Technology , 2010, Clinical orthopaedics and related research.
[10] Michael D Hill,et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. , 2010, The New England journal of medicine.
[11] Francis S Collins,et al. Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. , 2010, JAMA.
[12] Kirsten Bibbins-Domingo,et al. Projected effect of dietary salt reductions on future cardiovascular disease. , 2010, The New England journal of medicine.
[13] D. Hirtz,et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. , 2010, The New England journal of medicine.
[14] Alec B. O’Connor. Building comparative efficacy and tolerability into the FDA approval process. , 2010, JAMA.
[15] N. Dahodwala,et al. Emerging Subspecialties in Neurology: Health services research , 2010, Neurology.
[16] Eric E. Smith,et al. Characteristics, Performance Measures, and In-Hospital Outcomes of the First One Million Stroke and Transient Ischemic Attack Admissions in Get With The Guidelines-Stroke , 2010, Circulation. Cardiovascular quality and outcomes.
[17] Evelyn P Whitlock,et al. White Paper on CTSA Consortium Role in Facilitating Comparative Effectiveness Research , 2010, Clinical and translational science.
[18] F. Collins. Opportunities for Research and NIH , 2010, Science.
[19] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[20] A. Berg. The CDC's EGAPP initiative: evaluating the clinical evidence for genetic tests. , 2009, American family physician.
[21] S. Hauser,et al. IOM task impossible: Set the agenda for neurological comparative effectiveness research , 2009, Annals of neurology.
[22] D. Thurman,et al. Disparities in epilepsy: Report of a systematic review by the North American Commission of the International League Against Epilepsy , 2009, Epilepsia.
[23] Robert H Brook,et al. Possible outcomes of comparative effectiveness research. , 2009, JAMA.
[24] Vivian Gu,et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. , 2008, The New England journal of medicine.
[25] Brian S Mittman,et al. Overview of the VA Quality Enhancement Research Initiative (QUERI) and QUERI theme articles: QUERI Series , 2008, Implementation science : IS.
[26] W. Meurer,et al. Qualitative data collection and analysis methods: the INSTINCT trial. , 2007, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[27] S. Horn,et al. Practice-Based Evidence Study Design for Comparative Effectiveness Research , 2007, Medical care.
[28] David F. Smith,et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial , 2007, The Lancet.
[29] J. Westfall,et al. Practice-based research--"Blue Highways" on the NIH roadmap. , 2007, JAMA.
[30] E. Dooley. National Institute of Neurological Disorders and Stroke , 2006 .
[31] Robert G. Miller,et al. Factors correlated with NPPV use in ALS , 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[32] S. Kasner,et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. , 2005, The New England journal of medicine.
[33] Pamela W Duncan,et al. Ethnic Disparities in Stroke: Epidemiology, Acute Care, and Postacute Outcomes , 2005, Stroke.
[34] D. Altman,et al. CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.
[35] R. Teasell,et al. Intensity of Aphasia Therapy, Impact on Recovery , 2003, Stroke.
[36] Stephen B. Johnson,et al. Central challenges facing the national clinical research enterprise. , 2003, JAMA.
[37] N. Powe,et al. Designing and evaluating interventions to eliminate racial and ethnic disparities in health care , 2002, Journal of general internal medicine.
[38] J A Fleishman,et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. , 1999, JAMA.
[39] Giovanni Parmigiani,et al. The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions , 1997, Annals of Internal Medicine.
[40] M A Hlatky,et al. Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization. , 1996, The New England journal of medicine.
[41] M. B. Brown,et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study , 1995, Neurology.
[42] F. Mosteller,et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.
[43] J. Cramer,et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. , 1985, The New England journal of medicine.
[44] R. Cicerone. Initial National Priorities for Comparative Effectiveness Research , 2009 .
[45] Sean,et al. Research on the Comparative Effectiveness of Medical Treatments: Isues and Options for an Expanded Federal Role , 2007 .
[46] Adrienne Y. Stith,et al. Unequal treatment: confronting racial and ethnic disparities in health care. , 2003 .
[47] R Whurr,et al. Speech and language therapy for aphasia following stroke. , 2000, The Cochrane database of systematic reviews.
[48] T. Imperiale. Meta-analyses and large randomized, controlled trials. , 1998, The New England journal of medicine.
[49] David R. Williams,et al. Race and Health: A Multidimensional Approach to African American Health , 1995 .